Monopar Therapeutics Inc.MNPRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeExpanding
Percentile Rank100
3Y CAGR+368.4%
5Y CAGR+60.6%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+368.4%/yr
vs -9.1%/yr prior
5Y CAGR
+60.6%/yr
Recent acceleration
Acceleration
+377.5pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
10.7x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$2.18M+279.3%
2024$575302.00+34.1%
2023$429039.00+1920.1%
2022$21239.00-11.6%
2021$24024.00-88.2%
2020$204302.00+106.6%
2019$98887.00+217.5%
2018$31147.00-35.5%
2017$48255.00+567.2%
2016$7232.00-